Natera Unveils AI Foundation Models to Boost Diagnostic Innovation
Proprietary platform is constructed on one of many largest multimodal oncology datasets, together with 250,000+ tumor exomes, 1 million+ plasma timepoints, and enriched medical and imaging data Natera, Inc. (NASDAQ: NTRA), a world chief in cell-free DNA and precision drugs, at present introduced the launch of its proprietary AI basis mannequin platform. These fashions and purposes,…
